INTRODUCTION
============

Lumbar discectomy is the most common surgical procedure performed for patients experiencing back and leg pain. Despite high rates of safety and success in relieving pain and improving function, between 10% and 30% of discectomy patients continue to experience unsatisfactory results[@B6],[@B7],[@B8],[@B21]. Loss of disc height[@B4],[@B27] and recurrent disc herniation[@B7],[@B16] have been identified as important factors contributing to poor outcomes following lumbar discectomy.

To prevent reherniation, traditionally a subtotal discectomy has been recommended with removal of as much of the disc nucleus as possible. This practice, however, leads to increased disc disruption with loss of disc height, which will transfer axial loads radially to the annulus fibrosus and to the facet joints of the posterior column, thus contributing to long-term back pain[@B1],[@B10].

Attempting to minimize these effects, a limited discectomy procedure has been proposed, aiming to remove only the offending disc fragment and any loose disc material without further invading the disc space. Limited discectomy, however, is associated with a greater incidence of recurrent disc herniation[@B7],[@B17],[@B26].

Carragee et al. showed that the rate of reherniation after limited discectomy was greatest (27.3%) in patients with annulus defects wider than 6mm, and suggested that a barrier to close the defect in these patients may be clinically useful in preventing reherniation[@B5]. In addition, by reinforcing the disc annulus, such a barrier may also contribute to maintenance of disc pressure and height, thus preserving disc function and possibly retarding further degeneration of the disc and facet joints.

Previous attempts to close the annulus defect have failed because they relied on the strength and stability of the remaining annulus which usually falls short[@B13]. Recently, an annulus closure device was developed consisting of a flexible polyester mesh to close the defect. The mesh is attached to a titanium bone anchor implanted into the adjacent vertebral body, providing stable footing for the implant that is better able to withstand the high pressures within the disc.

We prospectively evaluated the safety and efficacy of this new annulus closure device when used as an adjunct to primary limited discectomy in patients with symptomatic disc herniation refractory to conservative treatment. In this paper, the first 12 months of follow-up of this 24-month study are reported.

MATERIALS AND METHODS
=====================

This multi-center, prospective study (clinicaltrials.gov ID NCT01534065) was initiated with Medical Ethics Committee approval for each site. Forty-five patients were enrolled in this study. Patients who in the surgeon\'s opinion seemed eligible for this study were asked to participate and screened for eligibility. All patients had sciatica due to an MRI-confirmed lumbar disc herniation unresponsive to conservative therapy for at least 6 weeks. Further select inclusion and exclusion criteria for study participations are listed in [Table 1](#T1){ref-type="table"}.

Posterior lumbar discectomy with limited nucleus removal and implantation of the annulus closure device was performed in the patients at four sites. After informed consent, all subjects were assessed preoperatively and postoperatively at 6 weeks and at 3, 6, and 12 months. Low back and radicular leg pain were evaluated using a visual analog scale (VAS). The Oswestry Disability Index (ODI) was administered to assess function. Antero-posterior, neutral lateral, and flexion-extension radiographs were obtained at all evaluation intervals. Multiplanar computed tomography (CT) and magnetic resonance imaging (MRI) were obtained preoperatively and postoperatively at 12 months. Analysis by an independent radiology lab (Medical Metrics, Inc.; Houston, TX, USA) was conducted to assess radiographic data, including all MR images to identify asymptomatic recurrent herniations. Preoperative and postoperative disc space height at the involved level was measured at the anterior and posterior edges of the endplates using neutral lateral radiographs[@B23]. Postoperative radiographs also were examined for evidence of heterotopic bone formation (bridging of trabecular bone/fusion between the vertebrae), device subsidence/migration, and device condition (intact or fractured). In addition, the degree of facet arthropathy and disc degeneration was assessed using validated grading scales[@B20],[@B22]. Complications and subsequent surgeries were monitored and documented throughout the study. The study was monitored by an independent Data Safety Monitoring Board who reviewed all safety-related issues, including adverse events and protocol violations (see appendix).

Preoperative clinical data were compared to postoperative data at 6 weeks, 3 months, 6 months, and 12-months. For contin uous, paired variables that were normally distributed, a paired t-test was used to determine statistical significance. Wilcoxon Signed Rank Test was used to compare paired, ordinal variables or continuous, paired variables that were not normally distributed. Missing data were not estimated or carried forward in any statistical analyses. Statistical differences were considered significant when the p-value was less than or equal to 0.05. Statistical analysis was performed using SigmaStat® Software, version 2.0 (SPSS, Inc., Chicago, Illinois).

1. Device Description
---------------------

The Barricaid® (Intrinsic Therapeutics, Inc., Woburn, MA, USA) annulus closure device was designed as an adjunct to lumbar discectomy to block the annulus defect and maintain nucleus within the disc space. The device has received CE-marking and is comprised of two components: a flexible mesh that prevents migration of the nucleus from within the disc, and a bone anchor which secures the occlusion component to one of the adjacent vertebral bodies ([Figs. 1](#F1){ref-type="fig"} and [2](#F2){ref-type="fig"}). The anchor is composed of Ti6Al-4V ELI, a typical orthopedic alloy with a long history of use in permanent implants. The mesh is made up of woven polyester (\"Dacron\"), which has been in use for implantation as cardiovascular graft material in humans for several decades.

At the time of the study, the implant was available in one size capable of blocking an annulus defect up to 10 mm wide.

2. Surgical Technique
---------------------

Each surgery was carried out by one of eight neurosurgeons, all well-experienced in lumbar disc surgery. Prior to study initiation, surgeons took an instructional course which included \"hands-on\" training of inserting the Barricaid® device in cadaver specimens or in an artificial lumbar spine, though none had implanted any in living humans. In all subjects, a limited discectomy was performed. Any disc material removed, either from within or outside the disc space, was placed dry in a syringe and the volume was measured and recorded. After completion of the discectomy, the size of the annulus defect was measured using sizing probes of 1mm increments. If the defect was taller than 6mm or wider than 10mm, implantation of the annulus closure device was not attempted. In no case, however, the defect exceeded these size limits. Subsequently, a sizing trial, designed to replicate the size and shape of the loaded delivery tool, was used to confirm access through the lamina and the appropriate angle of approach to the disc. Then the delivery tool was placed in the disc under fluoroscopic control, ensuring that the angle of approach was parallel to the target endplate in the region of implantation. Holding the delivery tool firmly in position, the anchor was hammered into the endplate, thereby simultaneously placing the mesh in position within the disc ([Fig. 3](#F3){ref-type="fig"}).

Patients were discharged and given post-surgery care instructions per each hospital\'s standard regimen following lumbar discectomy, without any additional bracing or other activity restrictions.

RESULTS
=======

Between April 2009 and July 2010, 45 patients provided written informed consent and were enrolled in the study. The baseline, demographic, clinical, radiographic and intra-operative characteristics of the study population are provided in [Table 2](#T2){ref-type="table"}. One subject had a concomitant musculoskeletal condition (arthritis), and one subject had a previous back procedure, a unilateral decompression at another level.

A flowchart depicting subject accounting is provided in [Fig. 4](#F4){ref-type="fig"}. One subject was not implanted due to a technical error, one subject was excluded from analysis because of an intraoperative protocol violation, and two subjects failed to return for the 12-month follow-up. One patient\'s implant was removed after approximately 6 months as described in detail below, thus leaving 40 subjects for comparative analysis of pre- and post-operative patient-reported clinical data. One subject was included in the study despite having a VAS-leg \<40 (35/100).

1. Clinical results
-------------------

Pre- and post-operative VAS scores for back pain and ipsilateral leg pain for these 40 patients are depicted in [Figure 5](#F5){ref-type="fig"} (back pain) and [Fig. 6](#F6){ref-type="fig"} (leg pain). Significant reductions in VAS scores were noted following surgery throughout the 12 months follow-up period (p\<0.0001, Wilcoxon Rank-Sum test). ODI scores followed a similar course ([Fig. 7](#F7){ref-type="fig"}) and were significantly lower postoperatively compared to baseline (p\<0.0001, Wilcoxon Rank-Sum test).

2. Radiographic results
-----------------------

As depicted in the patient flowchart in [Fig. 4](#F4){ref-type="fig"}, radiographic data necessary to evaluate disc height were available for 30 of these 40 patients. There was a small but significant decrease of the mean disc height to 92.8% of baseline (S.D. 7.9%) ([Fig. 8](#F8){ref-type="fig"}) at 12 months (p\<0.01, one-sided Student t-test). No statistically significant differences were found between mean preoperative and 12-month evaluations for disc angle, spondylolisthesis, rotation and translation. Furthermore, no evidence was found of heterotopic ossification or spontaneous fusion. In all cases, the device was intact, with no signs of subsidence or migration. The degree of facet joint arthopathy and disc degeneration preoperative and at 12 months are presented in [Tables 3](#T3){ref-type="table"} and [4](#T4){ref-type="table"}. The differences noted were not statistically significant (Fisher\'s Exact: p=0.781 for facet joint arthropathy and p=0.857 for disc degeneration)

3. Reherniation and other adverse events
----------------------------------------

As depicted in the patient flowchart in [Fig. 4](#F4){ref-type="fig"}, one (2.4%) of the 41 subjects evaluable for reherniation at twelve months had a symptomatic reherniation and required a subsequent reo peration. The subject was a 40 year-old male who was a current smoker with a body mass index (BMI) of 22.1. Primary surgery was an L4-5 discectomy with the annulus closure device implantation performed to treat a defect with an area of 32 mm^2^ (4mm tall by 8mm wide) following removal of 1.3mL of nucleus. Four months after surgery, the patient reported an increase in back and leg pain and a recurrent herniation was confirmed on MR. Clinical assessment at 6 months showed an increase in low back pain VAS (from 14/100 to 59/100); no device subsidence, migration, or spontaneous fusion was observed radiographically. The annulus closure device was remo ved and a posterior lumbar interbody fusion was performed. The operating surgeon and the DSMB independently concluded that the annulus closure device was implanted 3 mm too deep into the disc space, which exceeded the range in the described surgical technique, permitting the development of a nuclear extrusion around the device. This patient continues to have back pain at the 12 month follow-up, with a VAS back of 87/100, ODI 46/100, and VAS leg of 16/100.

Of the remaining 40 subjects evaluable for reherniation at 12 months, MRIs were available for 36. Review of these images revealed that one subject (2.8%) exhibited evidence of an asymptomatic nuclear extrusion in the region of the Barricaid®, maximal 6mm beyond the confines of the annulus fibrosus but still in contact with the disc on imaging. At the index surgery, subject was a 43 year-old male smoker with a BMI of 25.2. An L4-5 discectomy with annulus closure device implantation was performed to treat a defect with an area of 40mm^2^ (5 mm tall by 8 mm wide) following removal of 2.5 mL of nucleus. At 12months, clinical assessment revealed improvements in this subject\'s leg pain VAS (from 76/100 pre-op to 2/100 at 12 months) and Oswestry (from 48/100 to 26/100) and a slight increase in low back pain VAS (from 27/100 to 32/100). This subject continues to be clinically asymptomatic and is undergoing routine monitoring.

No other reherniations were reported. Two other reoperations were performed, one for a contralateral herniation three weeks following the index surgery, and one for excessive scar tissue five months following the index surgery.

According to the review by the DSMB, no device-related adverse events have occurred in the study population. Of the 17 subjects who have reached the two-year time point, all had 24-month follow-up safety data available. None of these had evidence of recurrent disc herniation or device migration, subsidence, or fracture/disassembly. No dural tears were reported in this study

DISCUSSION
==========

Placement of an annulus closure device following limited discectomy yielded short-term results in terms of reduced leg and back pain that were as good as those of limited discectomy alone[@B3],[@B7]. No device-related adverse events have occurred throughout the course of study. In addition, 12-month and initial 24-month radiographic analysis revealed intact devices, with no evidence of subsidence or migration. These results support a favorable initial safety profile for this annulus closure device within 12 months following surgery.

Although a long-term study is needed to fully assess the ability of this annulus closure device to prevent recurrent reherniations, the low rate of reherniation in this series suggests success in preventing early reherniations. Only one patient had a symptomatic reherniation (2.4%) within the first 12 months following surgery. The surgeon later determined that device malpositioning at the time of implantation in this case likely influenced the outcome, and the manufacturer has addressed this issue by developing a second generation delivery tool that limits implantation depth. A second reherniation that until now remains asymptomatic was identified on a prospective review of annual MRs by an independent radiology lab. An asymptomatic recurrence in patients treated with a limited discectomy is not unusual[@B4]. Recurrent disc prolapses without clinical symptoms may be present in as many as 13% of discectomy patients after two years following surgery[@B15]. The one asymptomatic reherniation we found in this study (2.8%) represents a reduced rate compared to discectomy patients in whom annulus closure was not performed. In one patient, a contralateral herniation occurred at the same level within 3 weeks after the index surgery. Contralateral herniations have been reported in 4% within one year following primary discectomy[@B19]. Yet, the possibility that implantation of the Barricaid resulted in a pressure increase in the disc that contributed to rupture of the annulus at the contralateral side cannot be excluded. This question may be answered in a randomized trial.

A review of the literature demonstrates that the reported incidence of symptomatic and/or reoperated recurrent herniation within 12 months following lumbar discectomy performed by a variety of techniques ranges from 0-18.1%[@B2],[@B3],[@B11],[@B12],[@B17],[@B19],[@B24],[@B25]. Not all patients have an equivalent risk of reherniation. annulus defect size observed at the time of surgery has been implicated as a major risk factor for recurrence[@B17]. Carragee et al.[@B5] reported a reherniation rate for discs with \"massive\" defects (\>6 mm in width) that was almost six times greater when compared to the remaining patient cohort with smaller defects (27.3% vs. 4.8%), identifying this as \"an independent predictor of reherniation\". The vast majority (33 of 41) of annulus defects in the present study matched Carragee\'s definition of \"massive\", and were therefore at a significantly higher risk of reherniation than those with smaller defects.

The aggressive removal of nucleus from within the disc space has been a surgical technique to lower the reherniation rate, though this can lead to worse clinical outcomes[@B17]. One metaanalysis concluded that the higher reherniation rate associated with more limited discectomy (8.7% vs. 3.3% for aggressive nuclectomy) is offset by the decreased incidence of recurrent back and leg pain (11.% vs. 28%)[@B26]. In our study, use of an annulus closure device in patients treated with limited discectomy appears to have resulted in reherniation rates on par with more aggressive nucleus removal, but with the clinical benefits associated with retention of more of the native nucleus. These results were achieved despite a majority of patients having large annulus defects with a significantly increased risk of reherniation. It remains to be seen whether this combination of positive outcomes continues in the long-term.

The device also appears effective in maintaining disc height. The majority of discectomy patients experience greater than a 25% loss of preoperative disc height after surgery[@B4],[@B16],[@B18],[@B27], which has been associated with poor clinical outcomes, particularly low back pain[@B4],[@B27]. In our study, patients maintained an average of 92.8% of their pre-operative disc height at the 12-month follow-up with no significant difference between preoperative and 12-month values across the population. Volume of nucleus removed at the time of primary discectomy has been identified as a particularly significant factor associated with disc height loss following surgery[@B17]. The mean volume of nucleus removed in our study was indeed 20% less than the volume reported by McGirt et al[@B17]. In conclusion, the use of an annulus closure device may provide a reduction in reherniation rate for lumbar discectomy patients with large annulus defects who are at the greatest risk of recurrence. Using such a device should provide the surgeon increased confidence in reducing the volume of nucleus removed, which, in turn, may preserve disc height and biomechanics, reducing degeneration and associated poor clinical outcomes in the long-term.

Possible risks and complications associated with the device should also be considered. Implantation requires sufficient space to place the device into the disc defect without undue retraction of the nerve root while protecting the dura. This may be a problem with central disc herniations unless the dura and nerve root can be mobilized sufficiently. In the present series the device was used in central disc defects in 3 cases without complications. No dural tears or nerve root damage occurred in any patient. As with any implant, there is a risk of device migration, subsidence, loosening or fracture, and allergic reaction by the patient. None of these complications were encountered in this series so far. Scar formation may be another concern related to the introduction of a foreign body and associated surgical manipulations. In the present series, one patient had to be reoperated for excessive scar tissue. Scar tissue formation, however, is a relatively common finding after lumbar discectomy, the procedure for which the studied device is an adjunct. Kotilainen et al. reported that 4 of 237 (1.7%) discectomy patients required reoperation due to excessive scar tissue formation, and Daneyemez et al. reported that 26 of 1072 (2.4%) of discectomy patients required reoperation for epidural fibrosis, which is within the same rangeas in our study (1/45=2.2%)[@B9],[@B14]. A randomized controlled study will provide more information on the relative contribution of the annulus closure device to postoperative scarring.

Main study strengths include the prospective, multi-center design, use of a standard protocol with strict inclusion and exclusion criteria for patient selection, use of a standardized surgical technique and assessment tools, and independent evaluation of imaging and adverse events. Methodological weaknesses include lack of randomization, small sample size, and only preliminary follow-up. A prospective, randomized, multicenter study evaluating limited discectomy with and without the use of the annulus closure device is currently underway, and will provide a higher level of evidence regarding the device\'s safety and efficacy.

Clinical Trial Registration: clinicaltrials.gov ID NCT01534065

Patient follow-up and data analysis was financially supported by Intrinsic Therapeutics, Inc.
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###### Selected inclusion and exclusion criteria for study participation.
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###### Baseline study population and surgical data (mean±SD)
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###### Degree of facet joint arthopathy preoperative and at 12 months according to Pathria classification[@B20]

![](kjs-9-340-i003)

Fisher\'s Exact: p=0.781 comparing grade distribution preop vs. 12m

###### Degree of disc degeneration preoperative and at 12 months according to Pfirrmann classification[@B22]
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Fisher\'s Exact: p=0.857 comparing grade distribution preop vs. 12 m
